Compounded Semaglutide: What the FDA Says
Boxed warning: semaglutide and tirzepatide cause thyroid C-cell tumors in rodents, and whether they do in humans is unknown. They are contraindicated with a personal or family history of medullary thyroid carcinoma (MTC) or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). If you use a GLP-1 medication and could become pregnant: semaglutide (Ozempic, Wegovy) should be stopped at least 2 months before a planned pregnancy. If you take birth control pills while using tirzepatide (Zepbound, Mounjaro), the labels advise switching to a non-oral method or adding a barrier method for 4 weeks after starting and for 4 weeks after each dose increase. The Zepbound label says to stop it when pregnancy is recognized.
Compounded GLP-1s are cheaper, easier to get, and marketed hard. Before deciding, it is worth reading what the regulator says rather than what the seller says.
Talk to a physician about your optionsWhat "compounded" actually means
A compounded drug is prepared by a pharmacy rather than manufactured and approved as a finished product. Compounding has a real and legitimate role — for a patient who needs a different form of a medication, or cannot tolerate an ingredient in the approved version.
What it is not is a generic. Semaglutide and tirzepatide are still under patent, and no generic of either is marketed in the U.S. A compounded version has not been through the FDA review that the branded product went through, which is the distinction the marketing tends to blur.
The FDA’s stated concerns
The agency has published its concerns about unapproved GLP-1 drugs used for weight loss directly, and they are specific rather than general.
- Dosing errors. These products are frequently supplied in vials requiring the patient to measure a dose, rather than a pre-set pen. The FDA has received reports of people administering many times the intended dose.
- Unapproved salt forms. Some products have used salt forms of the active ingredient, such as semaglutide sodium and semaglutide acetate, that are different active ingredients than those in the approved drugs. The FDA says it is not aware of any lawful basis for their use in compounding.
- Adverse events including hospitalization. The FDA has received such reports.
- Under-reporting. The agency notes explicitly that adverse events from compounded versions are likely under-reported, because state-licensed pharmacies that are not outsourcing facilities are not required to report them to FDA.
Source: U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss
Questions worth asking before you buy
If you are considering a compounded product anyway — and people do, for reasons of cost that are entirely real — these are the questions that separate a considered decision from a hopeful one.
- Which pharmacy is compounding it, and is it a state-licensed pharmacy or a registered outsourcing facility?
- Which form of the active ingredient is being used — the base, or a salt form?
- Am I measuring my own dose from a vial? If so, who is checking that I am doing it correctly?
- Who do I contact if something goes wrong, and will that event be reported anywhere?
- Is a licensed clinician evaluating me, or is this a questionnaire?
Why a surgical practice is telling you this
A fair question, and the honest answer is that we would rather you had accurate information than that you chose surgery. Plenty of people should be on an approved GLP-1 and not in an operating room, and this page is not an argument against medication.
It is an argument against a particular supply route, made by pointing at what the regulator has actually published. If you decide a compounded product is right for you, you should make that decision knowing what the FDA has said about it.
Common questions
Is compounded semaglutide legal?
Compounding itself is a legitimate and regulated activity. What has changed repeatedly is the scope of what compounders may produce and under which conditions, and the rules differ between state-licensed pharmacies and registered outsourcing facilities. Because that position has moved several times, check the FDA’s current published statements rather than relying on a summary — including this one.
Is it the same drug as Ozempic or Wegovy?
Not necessarily. The FDA says salt forms, such as semaglutide sodium and semaglutide acetate, are different active ingredients than those in the approved drugs, and that it is not aware of any lawful basis for their use in compounding.
Is there a generic version?
No. Semaglutide and tirzepatide are still under patent, and no generic of either is marketed in the U.S. Anything marketed to you as "generic Ozempic" or "generic Zepbound" is not that.
Why is it so much cheaper?
Because it has not been through the approval process, manufacturing and post-market surveillance that the branded product has. That is the trade being made, and it is worth making knowingly.
What is the actual risk?
The FDA lists dosing errors, unapproved salt forms, and adverse events including some requiring hospitalization. It also says those events are likely under-reported, because state-licensed pharmacies that are not outsourcing facilities are not required to report them to the agency.
I am already taking one. What should I do?
Do not stop abruptly on the strength of a web page — talk to a clinician. Bring the vial and its labeling with you, because which pharmacy prepared it and which form of the ingredient it contains are the details that matter.
Medically reviewed by Dr. David G. Davtyan, MD, FACS, FICS, FASMBS, California medical license G 70030. Last reviewed August 24, 2026. This page is general information about treatment options and is not medical advice, a dosing instruction, or a substitute for consultation.
